Introduction
============

Photodynamic therapy (PDT) is an advancing medical technology that uses photosensitizing drugs. When the photosensitizing agent is exposed to an appropriate wavelength of light, reactive oxygen species (ROS) are produced which may kill nearby tumor cells ([@b1-or-39-01-0061]--[@b5-or-39-01-0061]). Unlike conventional therapeutics, PDT can selectively destroy tumor tissues, as well as control and reduce the degree of damage to normal tissues. Photosensitizers play a key role in PDT. Currently, only a few porphyrin photosensitizers (e.g. 5-aminolevulinic acid, temoporfin) are approved for the treatment of cancer in humans. Although these photosensitizers have demonstrated a wide spectrum of antitumor effects, they have various deficiencies. Thus, the development of better photosensitizing candidate drugs is required. Phthalocyanines, which have desirable electronic absorption and photophysical properties, are some of the most promising potential photosensitizer candidates. Phthalocyanines have a hydrophilic/lipophilic structure. The hydrophilic group enhances the transport of the drug in the body and the lipophilic group enhances the uptake of the drug by the cancer cells. Recently, accumulating evidence revealed that PDT using hydrophilic/lipophilic phthalocyanines achieved highly selective antitumor effects ([@b6-or-39-01-0061]--[@b9-or-39-01-0061]).

Mitochondria play a pivotal role in the initiation and amplification of most apoptotic pathways. When mitochondria are stimulated by apoptotic signals, the mitochondrial membrane-permeability is increased, leading to the release of cytochrome *c* (Cyto *c*) and the apoptosis-inducing factor (AIF) into the cytoplasm resulting in mitochondria-mediated apoptosis ([@b10-or-39-01-0061]--[@b16-or-39-01-0061]). Additionally, mitochondria are regulated by the Bcl-2 family, the caspase family and the mitogen-activated protein kinase (MAPK) proteins ([@b17-or-39-01-0061]--[@b22-or-39-01-0061]). The Bcl-2 family of proteins are a group of evolutionarily related apoptosis-regulation proteins that regulate mitochondrial membrane-permeabilization; Bax and Bid are pro-apoptotic proteins and Bcl-2 is an anti-apoptotic protein. Recent studies demonstrated that the mitochondrial transmembrane potential of cancer cells is altered by phthalocyanine-PDT ([@b23-or-39-01-0061],[@b24-or-39-01-0061]).

Caspase-9, a member of the caspase family of proteases, is the main executor of apoptosis signaling. Once activated, initiator caspase-9 cleaves effector caspase-3, which subsequently, induces the morphological and functional changes associated with apoptosis. Accumulating evidence has demonstrated that caspase-9 and caspase-3 play crucial regulatory roles in the phthalocyanine-PDT-induced apoptosis of cancer cells ([@b23-or-39-01-0061],[@b24-or-39-01-0061]). In addition, accumulating evidence has revealed that caspase-9 is involved in the regulation of cell autophagy and is an important determinant of the balance between cell apoptosis and autophagy ([@b25-or-39-01-0061],[@b26-or-39-01-0061]).

MAPKs, a family of protein serine/threonine kinases, include extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal protein kinase (JNK) and p38 kinase. MAPKs are activated in response to cellular stimuli and are involved in the regulation of cellular processes such as proliferation, apoptosis and autophagy ([@b27-or-39-01-0061],[@b28-or-39-01-0061]). Among the MAPKs subfamily, p38 MAPK-activation is mainly implicated in stress stimuli (oxidative stress, ultraviolet irradiation, chemotherapeutics, hyperthermia)-induced apoptosis ([@b29-or-39-01-0061],[@b30-or-39-01-0061]). Accumulating evidence has indicated that p38 MAPK activation plays a crucial regulatory role in phthalocyanine-PDT-induced apoptosis of cancer cells ([@b8-or-39-01-0061],[@b31-or-39-01-0061],[@b32-or-39-01-0061]).

Our previous study demonstrated that p38 MAPK and caspase-8 regulated the apoptosis of Bel-7402 human hepatocellular carcinoma cells induced by hydrophilic/lipophilic tetra-α-(4-carboxyphenoxy) phthalocyanine zinc (TαPcZn)-PDT ([@b6-or-39-01-0061],[@b8-or-39-01-0061]). However, the manner through which p38 MAPK or caspase-9 regulated mitochondria-mediated apoptosis in LoVo human colon carcinoma cells treated with TαPcZn-PDT is not clear. In the present study, a siRNA targeting *p38 MAPK* mRNA (siRNA-*p38 MAPK*) and the caspase-9-specific inhibitor z-LEHD-fmk were used to investigate the crosstalk between p38 MAPK and caspase-9 as part of apoptosis in the TαPcZn-PDT-treated LoVo cells. The findings indicated that p38 MAPK in a crosstalk between p38 MAPK and caspase-9 may play an important regulatory role and that direct crosstalk between p38 MAPK and caspase-9 may regulate mitochondria-mediated apoptosis in the TαPcZn-PDT-treated LoVo cells.

Materials and methods
=====================

### Antibodies and reagents

Dulbecco\'s modified Eagle\'s medium (DMEM), opti-MEM, Silencer Select siRNA-*p38 MAPK*, negative control siRNA, GAPDH positive control siRNA and lipofectamine RNAiMAX were all purchased from Thermo Fisher Scientific (Carlsbad, CA, USA). Fetal bovine serum (FBS) was purchased from PAA Laboratories (Cölbe, Germany). Diethyl sulfoxide (DMSO) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Anti-p38 MAPK, anti-phosphorylated (p)-p38 MAPK, anti-Bcl-2, anti-Bax, anti-AIF, anti-Cyto *c*, anti-Bid, anti-caspase-9 and anti-caspase-3 antibodies were all purchased from Cell Signaling Technology (Danvers, MA, USA). The anti-β-actin antibody was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Z-LEHD-fmk was obtained from Merck Chemicals GmbH (Darmstadt, Germany). The Annexin V-FLUOS staining kit was purchased from Roche (Basel, Switzerland). The reverse transcription-polymerase chain reaction (RT-PCR) kit was obtained from Takara (Dalian, China). The 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) staining kit was purchased from Genmed Scientifics (Wilmington, DE, USA). Catch and Release v2.0 kit was purchased from Millipore (Billerica, MA, USA). TαPcZn was synthesized as described in our previous study ([@b33-or-39-01-0061]). The TαPcZn stock solution was prepared in DMSO and stored in the dark at 4°C. When used, the stock solution was appropriately diluted to obtain the desired concentration with a final DMSO concentration of 0.1%. All other chemicals and reagents were of analytical grade.

### Cell culture and treatment

The LoVo cells were obtained from Harbin Medical University (Harbin, China) and cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin and 100 mg/l streptomycin in a humidified atmosphere of 5% CO~2~ at 37°C. The LoVo cells were incubated for 48 h. After treatment with the TαPcZn stock solution for 2.5 h at 37°C in the presence or absence of siRNA-*p38 MAPK* or z-LEHD-fmk, the cells were irradiated with an SS-B instrument (Wuxi Holyglow Physiotherapy Instrument Co., Ltd., Jiangsu, China) that emitted red light within a wavelength of 600--700 nm. The light dose was \~53.7 J/cm^2^. The cells were harvested after 3 h. The control cells were exposed to red light irradiation (53.7 J/cm^2^).

### siRNA transfection

The cells were transfected with siRNAs using lipofectamine RNAiMAX reagent according to the manufacturer\'s instructions and assayed 48 h after transfection. Control non-targeting siRNA, GAPDH positive control siRNA and siRNA against *p38 MAPK* (12.5 nM) were all obtained from Thermo Fisher Scientific. The target sequence of the *p38 MAPK* siRNA was 5′-GAAGCUCUCCAGACCAUUUTT-3′. The silencing efficiency was validated by RT-PCR and immunoblot analysis.

### Semi-quantitative RT-PCR

Total cellular RNA was extracted and the cDNA was synthesized using standard protocols. PCR primers specific for p38 MAPK (forward, 5′-GACAATCTGGGAGGTGCC-3′ and reverse, 5′-GACCCAGTCCAAAATCCA-3′) and GAPDH (forward, 5′-GAAGGTGAAGGTCGGAGTC-3′ and reverse, 5′-GAAGATGGTGATGGGATTTC-3′) were applied. RT was performed on 1 µg total RNA with a reaction mixture containing 10 µl denatured RNA in a 96-well thermal cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA), 1 µl 10X RT buffer, 2 µl (12.5 mM) MgCl~2~, 1 µl dNTP mix, 0.5 µl AMV reverse transcriptase, 0.5 µl Oligo dT-adaptor primer, 0.25 µl RNase inhibitor and 3.75 µl distilled water. cDNA was synthesized by incubation at 30°C for 10 min and then 42°C for 30 min, 99°C for 5 min and 5°C for 5 min. The PCR was performed on 5 µl cDNA product, which was added to a 20-µl PCR mixture comprised of 5 µl PCR Buffer, 0.125 µl Takara Ex Taq HS, 0.5 µl forward and reverse primers and 14.375 µl distilled water. The PCR reaction was carried out using one cycle at 94°C for 2 min, followed by 35 cycles at 94°C for 30 sec, annealing at 59°C for 30 sec, polymerization at 72°C for 1 min and a final extension at 72°C for 10 min. The RT-PCR products were separated by electrophoresis in 1.5% agarose gels and bands were visualized and quantified on a Molecular Imager^®^ Gel Doc™XR system with Image Lab™ software v.4.1 (Bio-Rad Laboratories). The samples exhibiting 220 and 460 bp bands were considered positive. GAPDH was used as an internal control. Densitometric quantifications of the objective RNA levels were made relative to GAPDH. Quantitative data were presented as the mean ± standard deviation (SD)from three independent experiments and were analyzed using an analysis of variance (ANOVA).

### Annexin V-FLUOS/Propidium iodide (PI) double-staining analysis of apoptosis

Cell apoptosis was assayed using the Annexin V-FLUOS/PI apoptosis detection kit. The harvested LoVo cells were washed with ice-cold PBS and suspended in 500 µl Annexin V binding buffer A, after which 100 µl aliquots were collected. Subsequently, 2.0 µl Annexin V-FLUOS and 2.0 µl PI were added and the mixture was incubated for 5 min in the dark at room temperature. After 5 min, 400 µl binding buffer was added to the cells and 1×10^4^ cells were analyzed on a FACScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) using CellQuest software. The results are shown as dotplots. In each graph, the percentage of apoptotic cells is indicated in the right upper and lower quadrant; the y-axis corresponds to the relative PI staining and the x-axis corresponds to the log of the FLUOS signal.

### JC-1 assay of the mitochondria membrane potential (ΔΨm)

The ΔΨm was assayed by JC-1 assay using fluorescence microscopy and flow cytometry. For the fluorescence microscopic analysis, after being treated with TαPcZn-PDT in the absence or presence of siRNA-*p38 MAPK* or z-LEHD-fmk, the cells were incubated in fresh culture medium containing 2.5 µg/ml JC-1 for 20 min in the dark at 37°C and washed twice with PBS and then, assayed using an inverted fluorescence microscope (Chongqing Photoelectric Instruments Co. Ltd., Chongqing, China). For the flow cytometric analysis, after being treated with TαPcZn-PDT in the absence or presence of siRNA-*p38 MAPK* or z-LEHD-fmk, the cells were trypsinized and washed twice with PBS and then incubated in PBS containing 2.5 µg/ml JC-1 for 20 min in the dark at 37°C. About 1×10^4^ cells were analyzed on a FACScan flow cytometer (Becton Dickinson) using CellQuest software. The results observed by flow cytometry are demonstrated as dotplots. In each graph, the shift of fluorescence from red to green indicated the collapse of the ΔΨm.

### Immunoblot assay

All immunoblots were performed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) according to the manufacturer\'s instructions. To obtain total cellular protein, the LoVo cells were lysed in buffer containing 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl~2~, 0.2 mM ethylenediaminetetraacetic acid, 0.1% Triton X-100, 20 mM β-glycerophosphate, 0.5 mM dithiothreitol, 1.0 mM sodium orthovanadate, 0.1 mM okadaic acid and 1.0 mM phenylmethylsulfonyl fluoride. Equal amounts of protein lysate were run on 10% SDS-PAGE and electrophoretically transferred to polyvinylidene fluoride membranes. After blocking, the blots were incubated with specific primary antibodies (anti-p38 MAPK, anti-phos-p38 MAPK, anti-caspase-3, anti-caspase-9, anti-Bcl-2, anti-Bax and anti-Bid antibodies) overnight at 4°C and further incubated for 1 h with horseradish peroxidase-conjugated secondary antibodies. Bound antibodies were detected using an enhanced chemiluminescence (ECL) kit with Lumino Image analyzer (Founder Group, Beijing, China). The mitochondria and cytosolic fractions isolated from the cells were collected for immunoblot assay of Cyto *c* and AIF, as previously described ([@b34-or-39-01-0061]). The Cyto *c* and AIF proteins were assayed using anti-Cyto *c* and anti-AIF antibodies. All densitometric quantifications of the protein levels were made relative to β-actin and expressed in arbitrary units.

### Immunoprecipitation/immunoblot assay

The cell lysates and the affinity ligands were incubated with the p38 MAPK antibody or caspase-9 antibody in a spin-column at 4°C overnight. After washing the column three times with 1X washing buffer, the protein was eluted from the column in native form. The immunoprecipitates were separated by 10% SDS-PAGE. After being transferred, the membranes were immunoblotted with the p38 MAPK antibody or caspase-9 antibody, washed with Tween-PBS and developed using the ECL system.

### Localized surface plasmon resonance (LSPR) signal detection

A COOH sensor chip was loaded into the OpenSPR instrument (Nicoya Lifesciences, Kitchener, ON, Canada), running buffer (1X PBS, pH 7.4) was pumped and 200 µl 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.04 mg/ml)/N-hydroxysuccinimide (0.06 mg/ml) mixture in the activation buffer was injected into the instrument. Subsequently, after 5 min, 200 µl anti-p38 MAPK antibody in PBS solution (8.55 µg/ml) was injected into the instrument. After 5 min, a 200 µl blocking solution was injected and then, after a further 5 min, 200 µl of treated-proteins in PBS (80 µg/ml) and 200 µl anti-caspase-9 antibody PBS solution (11.56 µg/ml) were injected into the instrument to assess the interactions between p38 MAPK, caspase-9 and total protein. The interactions were assayed by the resonance wavelength that was obtained by fitting the LSPR signals to the Lorentzian equation.

### Statistical analysis

All data are presented as the mean ± standard deviation (SD) and were analyzed using an analysis of variance (ANOVA). P\<0.05 was considered to indicate a statistically significant difference and P\<0.01 was considered to indicate a highly statistically significant difference in all cases. Statistical analyses were performed using SPSS version 18.0 (SPSS, Inc., Chicago, IL, USA).

Results
=======

### siRNA silencing of p38 MAPK

To analyze the effect of p38 MAPK silencing in the TαPcZn-PDT-treated LoVo cells, the cells were transfected with siRNA-*p38 MAPK*. The siRNA transfection rate was \~90% ([Fig. 1A and B](#f1-or-39-01-0061){ref-type="fig"}). After the siRNA-*p38 MAPK* transfection, the expression levels of *p38 MAPK* mRNA and p38 MAPK protein in the LoVo cells decreased significantly ([Fig. 1C-F](#f1-or-39-01-0061){ref-type="fig"}), indicating that siRNA silenced the expression of *p38 MAPK*.

### Effect of TαPcZn-PDT on the apoptosis of LoVo cells

The effect of TαPcZn-PDT on the apoptosis of LoVo cells was detected in several ways. Firstly, the morphological changes of the cells were observed using an inverted microscope. Compared with the control group, the TαPcZn-PDT group had a significantly greater proportion of cells exhibiting morphological characteristics of apoptosis, such as cell shrinkage and an increased number of vacuoles in the cytoplasm ([Fig. 2A](#f2-or-39-01-0061){ref-type="fig"}). In addition, cell apoptosis was quantitated by flow cytometric analysis of Annexin V-FLUOS/PI double-stained cells. Compared with the control treatment, TαPcZn-PDT significantly induced apoptosis of LoVo cells ([Fig. 2B](#f2-or-39-01-0061){ref-type="fig"}).

### Crosstalk between p38 MAPK and caspase-9 regulates the TαPcZn-PDT-induced apoptosis of LoVo cells

To evaluate whether p38 MAPK and caspase-9 are involved in the TαPcZn-PDT-induced apoptosis of LoVo cells, an immunoblot assay was used to investigate the effect of TαPcZn-PDT on p38 MAPK, p-p38 MAPK and caspase-9 with or without siRNA-*p38 MAPK* or z-LEHD-fmk. Compared with the control treatment, TαPcZn-PDT increased p38 MAPK phosphorylation and active caspase-9, but had less influence on p38 MAPK ([Fig. 3](#f3-or-39-01-0061){ref-type="fig"}). However, compared with TαPcZn-PDT treatment only, siRNA-*p38 MAPK* decreased the level of p38 MAPK and p-p38 MAPK and z-LEHD-fmk decreased the level of activated caspase-9 ([Fig. 3](#f3-or-39-01-0061){ref-type="fig"}).

siRNA-*p38 MAPK* and z-LEHD-fmk were used to assess whether p38 MAPK and caspase-9 regulated apoptosis in the TαPcZn-PDT-treated LoVo cells. Compared with the TαPcZn-PDT treatment only, siRNA-*p38 MAPK* and z-LEHD-fmk inhibited the TαPcZn-PDT-induced apoptosis of LoVo cells ([Fig. 2A and B](#f2-or-39-01-0061){ref-type="fig"}). Additionally, the results revealed that siRNA-*p38 MAPK* had a more significant inhibitory effect on TαPcZn-PDT-induced apoptosis compared with that of z-LEHD-fmk ([Fig. 2B](#f2-or-39-01-0061){ref-type="fig"}).

To evaluate whether p38 MAPK regulated caspase-9 and caspase-9 in turn regulated p38 MAPK, immunoblotting was performed to investigate the effect of siRNA-*p38 MAPK* on caspase-9 and the effect of z-LEHD-fmk on p38 MAPK during the TαPcZn-PDT-induced apoptosis in LoVo cells. Compared with the TαPcZn-PDT treatment alone, siRNA-*p38 MAPK* downregulated the expression of activated caspase-9 and z-LEHD-fmk downregulated the expression of p-p38 MAPK ([Fig. 3](#f3-or-39-01-0061){ref-type="fig"}).

To determine the manner in which p38 MAPK and caspase-9 regulated each other via crosstalk during the TαPcZn-PDT-induced apoptosis in LoVo cells, immunoprecipitation/immunoblot analysis was used to investigate the interaction between p38 MAPK and caspase-9 with or without siRNA-*p38 MAPK* or z-LEHD-fmk. Compared with the control treatment, TαPcZn-PDT upregulated p38 MAPK and caspase-9 ([Fig. 4A](#f4-or-39-01-0061){ref-type="fig"}), indicating that TαPcZn-PDT induced the formation of p38 MAPK/caspase-9 complexes. However, compared with the TαPcZn-PDT treatment alone, siRNA-*p38 MAPK* or z-LEHD-fmk downregulated p38 MAPK or caspase-9, respectively ([Fig. 4A](#f4-or-39-01-0061){ref-type="fig"}). Furthermore, the interaction between p38 MAPK and caspase-9 in the TαPcZn-PDT-induced apoptosis of LoVo cells was detected by an LSPR assay. Firstly, the LSPR signal shift was used to assess the interaction between p38 MAPK and the total cellular protein. Compared with the control treatment, TαPcZn-PDT markedly increased the LSPR signal shift ([Fig. 4B](#f4-or-39-01-0061){ref-type="fig"}), indicating that p38 MAPK bound to total protein. Secondly, the LSPR signal shift was used to detect the interaction between caspase-9 and the total protein/p38 MAPK complexes. Compared with the control treatment, TαPcZn-PDT obviously increased the LSPR signal shift ([Fig. 4C](#f4-or-39-01-0061){ref-type="fig"}), indicating that caspase-9 bound to the total protein/p38 MAPK complexes and to p38 MAPK.

### Crosstalk between p38 MAPK and caspase-9 regulates mitochondria in TαPcZn-PDT-induced apoptosis of LoVo cells

To assess whether the crosstalk between p38 MAPK and caspase-9 regulates mitochondria during the TαPcZn-PDT-induced apoptosis of LoVo cells, a JC-I assay was used to detect the influence of TαPcZn-PDT on ΔΨm with or without siRNA-*p38 MAPK* or z-LEHD-fmk. Compared with the control treatment, TαPcZn-PDT increased the number of green fluorescent apoptotic cells ([Fig. 5A](#f5-or-39-01-0061){ref-type="fig"}) and decreased the ratio of red/green fluorescence intensity ([Fig. 5B](#f5-or-39-01-0061){ref-type="fig"}). However, compared with TαPcZn-PDT treatment only, siRNA-*p38 MAPK* or z-LEHD-fmk decreased the number of green fluorescent apoptotic cells ([Fig. 5A](#f5-or-39-01-0061){ref-type="fig"}) and increased the ratio of red/green fluorescence intensity ([Fig. 5B](#f5-or-39-01-0061){ref-type="fig"}).

To further assess whether the crosstalk between p38 MAPK and caspase-9 regulates mitochondria during the TαPcZn-PDT-induced apoptosis of the LoVo cells, immunoblotting was performed to examine the levels of factors and proteins associated with mitochondria, including Bcl-2, Bax, AIF, Cyto *c*, Bid and caspase-3, with or without siRNA-*p38 MAPK* or z-LEHD-fmk treatment. Compared with the control treatment, TαPcZn-PDT significantly downregulated the expression of Bcl-2, upregulated the expression of Bax, promoted the release of AIF and Cyto *c* and activated Bid and caspase-3 ([Fig. 6A-C](#f6-or-39-01-0061){ref-type="fig"}). However, compared with the TαPcZn-PDT treatment alone, siRNA-*p38 MAPK* or z-LEHD-fmk attenuated the effects of TαPcZn-PDT on Bcl-2, Bax, AIF, Cyto *c*, Bid and caspase-3 ([Fig. 6A-C](#f6-or-39-01-0061){ref-type="fig"}). In addition, the results revealed that the inhibitory effect of siRNA-*p38 MAPK* on ΔΨm, Bcl-2, Bax, AIF, Cyto *c*, Bid and caspase-3 was more significant than the effects of z-LEHD-fmk on these factors in the TαPcZn-PDT-induced apoptosis of LoVo cells ([Figs. 5B](#f5-or-39-01-0061){ref-type="fig"} and [6A-C](#f6-or-39-01-0061){ref-type="fig"}).

Discussion
==========

Accumulating evidence has revealed that phthalocyanine-PDT induces apoptosis of tumor cells ([@b11-or-39-01-0061],[@b35-or-39-01-0061]). However, it was unclear whether TαPcZn-PDT induced the apoptosis of the LoVo cells. Therefore, the present study performed an initial investigation of this, confirming that TαPcZn-PDT induced apoptosis of LoVo cells.

p38 MAPK is an important signal in stress responses and caspase-9 is a key initiator in the mitochondrial apoptotic pathway ([@b36-or-39-01-0061]--[@b40-or-39-01-0061]). Recent studies revealed that p38 MAPK and caspase-9 were involved in the apoptotic process of tumor cells treated with phthalocyanine-PDT ([@b8-or-39-01-0061],[@b23-or-39-01-0061],[@b24-or-39-01-0061],[@b32-or-39-01-0061],[@b41-or-39-01-0061]). However, the mechanism through which p38 MAPK and caspase-9 regulated the TαPcZn-PDT-induced apoptosis of LoVo cells remains unclear. Therefore, we examined the effect of TαPcZn-PDT on p38 MAPK, p-p38 MAPK and caspase-9 levels, in combination with siRNA-*p38 MAPK* or z-LEHD-fmk. The results indicated that TαPcZn-PDT activated p38 MAPK and caspase-9, but siRNA-*p38 MAPK* and z-LEHD-fmk both reduced the level of activated p38 MAPK and caspase-9, indicating that the activation of p38 MAPK and caspase-9 may be involved in the TαPcZn-PDT-induced apoptosis of LoVo cells. To assess whether p38 MAPK and caspase-9 regulated apoptosis in the TαPcZn-PDT-treated LoVo cells, we analyzed the effect of siRNA-*p38 MAPK* and z-LEHD-fmk on apoptosis. We observed that both siRNA-*p38 MAPK* and z-LEHD-fmk reduced apoptosis of TαPcZn-PDT-treated LoVo cells, indicating that activated p38 MAPK and caspase-9 are essential for TαPcZn-PDT-induced apoptosis of LoVo cells.

Certain studies have reported that p38 MAPK regulates caspase-9 during drug-induced apoptosis of tumor cells ([@b42-or-39-01-0061],[@b43-or-39-01-0061]). However, whether p38 MAPK and caspase-9 regulate each other has not been ascertained in the TαPcZn-PDT-induced apoptosis of LoVo cells. Therefore, we examined the effect of siRNA-*p38 MAPK* on caspase-9 and the effect of z-LEHD-fmk on p38 MAPK during TαPcZn-PDT-induced apoptosis of LoVo cells. The results revealed that siRNA-*p38 MAPK* decreased the activation of caspase-9 and that z-LEHD-fmk decreased the activation of p38 MAPK, indicating that the crosstalk regulation between p38 MAPK and caspase-9 is involved in the TαPcZn-PDT-induced apoptosis of LoVo cells. In addition, these findings indicated that the inhibitory effect of siRNA-*p38 MAPK* on the TαPcZn-PDT-induced apoptosis was more significant than the effect of z-LEHD-fmk on apoptosis, revealing that p38 MAPK may have an important regulatory role in the crosstalk between p38 MAPK and caspase-9 during apoptosis of these treated cells. To determine the manner in which p38 MAPK and caspase-9 regulate each other during the TαPcZn-PDT-induced apoptosis of LoVo cells, we investigated the interaction between p38 MAPK and caspase-9 with or without siRNA-*p38 MAPK* or z-LEHD-fmk. The results revealed that TαPcZn-PDT induced the formation of p38 MAPK/caspase-9 complexes, but siRNA-*p38 MAPK* or z-LEHD-fmk both decreased the formation of p38 MAPK/caspase-9 complexes, indicating that p38 MAPK may bind to caspase-9 and that p38 MAPK or caspase-9 can regulate their interaction. All of the aforementioned results indicated that p38 MAPK may play an important regulatory role in the crosstalk between p38 MAPK and caspase-9 and that direct interaction between p38 MAPK and caspase-9 may regulate apoptosis in the TαPcZn-PDT-treated LoVo cells.

Previous studies revealed that mitochondria play a crucial regulatory role in phthalocyanine-PDT-induced apoptosis ([@b23-or-39-01-0061],[@b24-or-39-01-0061]) and that p38 MAPK and caspase-9 regulated mitochondria during cell apoptosis ([@b44-or-39-01-0061]--[@b48-or-39-01-0061]). However, it was not clear whether p38 MAPK and caspase-9 regulated mitochondria in the TαPcZn-PDT-induced apoptosis of LoVo cells. Therefore, the effect of the TαPcZn-PDT treatment in combination with siRNA-*p38 MAPK* or z-LEHD-fmk on ΔΨm and mitochondria-related factors and proteins (Bcl-2, Bax, AIF, Cyto *c*, Bid and caspase-3) was investigated in the present study. The findings revealed that TαPcZn-PDT resulted in the reduction of ΔΨm, the downregulation of Bcl-2, the upregulation of Bax expression, the release of AIF and Cyto *c* and the activation of Bid and caspase-3, indicating the involvement of mitochondria in the process of TαPcZn-PDT-induced apoptosis. However, siRNA-*p38 MAPK* and z-LEHD-fmk both attenuated the effects of TαPcZn-PDT on ΔΨm, Bcl-2, Bax, AIF, Cyto *c*, Bid and caspase-3, indicating that the crosstalk between p38 MAPK and caspase-9 may regulate mitochondria during TαPcZn-PDT-induced apoptosis of LoVo cells. In addition, the results revealed that siRNA-*p38 MAPK* had a more significant inhibitory effect on ΔΨm, Bcl-2, Bax, AIF, Cyto *c*, Bid and caspase-3 than the effect of z-LEHD-fmk, indicating that p38 MAPK has a major regulatory role in the crosstalk between p38 MAPK and caspase-9 during the TαPcZn-PDT-induced apoptosis in this cell type. As caspase-9 is the downstream of mitochondria within the apoptosis pathway, caspase-9 may regulate the mitochondria upstream by directly influencing p38 MAPK during the crosstalk between p38 MAPK and caspase-9, which may explain the reason why p38 MAPK had a more significant influence on mitochondria than caspase-9 in the crosstalk between p38 MAPK and caspase-9.

In conclusion, our findings indicated that p38 MAPK in the crosstalk between p38 MAPK and caspase-9 may play a major regulatory role and direct crosstalk between p38 MAPK and caspase-9 may regulate mitochondria-mediated apoptosis in the TαPcZn-PDT-treated LoVo cells.
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![Silencing of p38 MAPK in LoVo cells. LoVo cells were transfected with siRNA-*p38 MAPK* (12.5 nmol/l), the negative control siRNA and the GAPDH positive control siRNA using Lipofectamine RNAiMAX. In the presence of Block-iT Alexa Fluor Red Fluorescent Control for 48 h, the LoVo cells were exposed to red light irradiation (53.7 J/cm^2^), incubated for 3 h and then, the transfected cells were observed using (A) an inverted microscope and (B) a fluorescence microscope. Following transfection, the expression levels of *p38 MAPK* mRNA and p38 MAPK protein were analyzed using (C and E) reverse transcription-PCR and (D and F) immunoblot assay, respectively. The LoVo cells were treated with Lipofectamine RNAiMAX only as the control treatment. GAPDH was used as an internal control. The values presented are representative of three independent experiments (mean ± standard deviation; \*\*P\<0.01, compared to the control treatment). Scale bar, 70 µm. siRNA, small interfering RNA; MAPK, mitogen-activated protein kinase.](OR-39-01-0061-g00){#f1-or-39-01-0061}

![Effect of siRNA-*p38 MAPK* or z-LEHD-fmk on the TαPcZn-PDT-induced apoptosis of LoVo cells. In the absence or presence of siRNA-*p38 MAPK* (12.5 nmol/l) for 48 h or z-LEHD-fmk (10 µmol/l) for 2.5 h, LoVo cells were treated with TαPcZn (54 µmol/l), exposed to red light irradiation (53.7 J/cm^2^), and then incubated for 3 h. The morphology of the apoptotic cells was observed by (A) microscopy and the percentage of apoptotic cells was assayed by (B) flow cytometric analysis of Annexin V-FLUOS/PI double-stained cells. Scale bar, 70 µm. Values presented are representative of three independent experiments (mean ± standard deviation; \*\*P\<0.01, compared with the control treatment; ^\#\#^P\<0.01, compared with the TαPcZn-PDT treatment; ^ΔΔ^P\<0.01, compared with the TαPcZn-PDT/siRNA-*p38 MAPK* treatment). siRNA, small interfering RNA; MAPK, mitogen-activated protein kinase; TαPcZn, tetra-α-(4-carboxyphenoxy) phthalocyanine zinc; PDT, photodynamic therapy.](OR-39-01-0061-g01){#f2-or-39-01-0061}

![Changes in p38 MAPK, p-p38 MAPK and caspsase-9 levels in response to treatment with TαPcZn-PDT, with or without siRNA-*p38 MAPK* or z-LEHD-fmk, in LoVo cells. Following treatment with siRNA-*p38 MAPK* (12.5 nmol/l) for 48 h or z-LEHD-fmk (10 µmol/l) for 2.5 h, the LoVo cells were treated with TαPcZn (54 µmol/l), exposed to red light irradiation (53.7 J/cm^2^) and then incubated for 3 h. The expression of p38 MAPK, p-P38MAPK and cleaved caspase-9 was analyzed by an immunoblot assay. The values presented are representative of three independent experiments (mean ± standard deviation; \*P\<0.05, \*\*P\<0.01, compared to the control treatment; ^\#^P\<0.05, ^\#\#^P\<0.01, compared with the TαPcZn-PDT treatment). siRNA, small interfering RNA; MAPK, mitogen-activated protein kinase; TαPcZn, tetra-α-(4-carboxyphenoxy) phthalocyanine zinc; PDT, photodynamic therapy.](OR-39-01-0061-g02){#f3-or-39-01-0061}

![Interaction between p38 MAPK and caspase-9 in the TαPcZn-PDT-induced apoptosis of LoVo cells. (A) In the absence or presence of siRNA-*p38 MAPK* (12.5 nmol/l) for 48 h or z-LEHD-fmk (10 µmol/l) for 2.5 h, LoVo cells were treated with TαPcZn (54 µmol/l), exposed to red light irradiation (53.7 J/cm^2^) and then incubated for 3 h. Immunoprecipitates with the p38 MAPK antibody or caspase-9 antibody from LoVo cells were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then, immunoblotted with the caspase-9 antibody or p38 MAPK antibody. (B) Real-time signal shift of interaction between the anti-p38 MAPK and the total protein from the LoVo cells and (C) real-time signal shift of interaction between the anti-caspase-9 and anti-p38 MAPK/total LoVo cell protein complex were assayed by localized surface plasmon resonance. The resonance wavelength was obtained by fitting localized surface plasmon resonance signals to the Lorentzian equation. siRNA, small interfering RNA; MAPK, mitogen-activated protein kinase; TαPcZn, tetra-α-(4-carboxyphenoxy) phthalocyanine zinc; PDT, photodynamic therapy.](OR-39-01-0061-g03){#f4-or-39-01-0061}

![Effect of TαPcZn-PDT treatment, with or without siRNA-*p38 MAPK* or z-LEHD-fmk, on ΔΨm in the LoVo cells analyzed by JC-1 staining assay. In the absence or presence of siRNA-*P38MAPK* (12.5 nmol/l) for 48 h or z-LEHD-fmk (10 µmol/l) for 2.5 h, the LoVo cells were treated with TαPcZn (54 µmol/l), exposed to red light irradiation (53.7 J/cm^2^) and then incubated for 3 h. (A) The red/green fluorescence intensity and (B) the ratio of red to green fluorescence intensity in LoVo cells were detected by JC-1 assay using fluorescence microscopy and flow cytometry, respectively. Scale bar, 70 µm. Values presented are representative of three independent experiments (mean ± standard deviation; \*\*P\<0.01, compared with control treatment; ^\#\#^P\<0.01, compared with TαPcZn-PDT treatment; ^ΔΔ^P\<0.01, compared with the TαPcZn-PDT/siRNA-p38 MAPK treatment). siRNA, small interfering RNA; MAPK, mitogen-activated protein kinase; ΔΨm, mitochondrial membrane potential; TαPcZn, tetra-α-(4-carboxyphenoxy) phthalocyanine zinc; PDT, photodynamic therapy.](OR-39-01-0061-g04){#f5-or-39-01-0061}

![Effect of TαPcZn-PDT treatment, with or without siRNA-p38 MAPK or z-LEHD-fmk, on Bcl-2, Bax, AIF, Cyto *c*, Bid and caspase-3 levels in LoVo cells analyzed by immunoblot assay. In the absence or presence of siRNA-*p38 MAPK* (12.5 nmol/l) for 48 h or z-LEHD-fmk (10 µmol/l) for 2.5 h, LoVo cells were treated with TαPcZn (54 µmol/l), exposed to red light irradiation (53.7 J/cm^2^) and then incubated for 3 h. The expression of (A) Bcl-2 and Bax, (B) AIF and Cyto *c* and (C) Bid and caspase-3 was analyzed by immunoblot assay. Values presented are representative of three independent experiments (mean ± standard deviation; \*\*P\<0.01, compared with the control treatment; ^\#^P\<0.05, ^\#\#^P\<0.01, compared with the TαPcZn-PDT treatment; ^Δ^P\<0.05, ^ΔΔ^P\<0.01, compared with the TαPcZn-PDT/siRNA-*p38 MAPK* treatment). siRNA, small interfering RNA; MAPK, mitogen-activated protein kinase; AIF, apoptosis-inducing factor; Cyto *c*, cytochrome *c*; TαPcZn, tetra-α-(4-carboxyphenoxy) phthalocyanine zinc; PDT, photodynamic therapy.](OR-39-01-0061-g05){#f6-or-39-01-0061}
